Increased cytochrome c correlates with poor survival in aggressive lymphoma

Oncology Letters

Volumn 1, Issue 2, 2010, Pages 227-230

  Wilkinson, Saraht ^a   Johnson, David B F ^b   Tardif, Heather L ^a   Tome, Margaret E ^a   Briehl, Margaret M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Jack H Skirball Center for Chemical Biology and Proteomics   (United States)

Author keywords

Cytochrome c; Diffuse large B cell lymphoma; Follicular lymphoma; Gene expression profiling; Mantle cell lymphoma

Indexed keywords

CYTOCHROME C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CELL CULTURE; CORRELATION ANALYSIS; DRUG RESISTANCE; FOLLICULAR LYMPHOMA; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH;

EID: 77955731618     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000040     Document Type: Article

References (14)

1. Tome ME and Briehl MM: Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis. Cell Death Differ 8: 953-961, 2001.
2. Tome ME, Baker AF, Powis G, Payne CM and Briehl MM: Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res 61: 2766-2773, 2001.
3. Tome ME, Lutz NW and Briehl MM: Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance. Biochim Biophys Acta 1693: 57-72, 2004.
4. Tome ME, Briehl MM and Lutz NW: Increasing the antioxidant defense in WEHI7.2 cells results in a more tumor-like metabolic profile. Int J Mol Med 15: 497-501, 2005.
5. Newmeyer DD and Ferguson-Miller S: Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112: 481-490, 2003.
6. Wang GQ, Gastman BR, Wieckowski E, Goldstein LA, Rabinovitz A, Yin XM and Rabinowich H: Apoptosis-resistant mitochondria in T cells selected for resistance to Fas signaling. J Biol Chem 276: 3610-3619, 2001.
7. Rosenwald A, Wright G, Chan WC, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947, 2002.
8. Dave SS, Wright G, Tan B, et al: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351: 2159-2169, 2004.
9. Rosenwald A, Wright G, Wiestner A, et al: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3: 185-197, 2003.
10. Tome ME, Johnson DB, Rimsza LM, Roberts RA, Grogan TM, Miller TP, Oberley LW and Briehl MM: A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood 106: 3594-3601, 2005.
11. Igamberdiev AU and Kleczkowski LA: Equilibration of adenylates in the mitochondrial intermembrane space maintains respiration and regulates cytosolic metabolism. J Exp Bot 57: 2133-2141, 2006.
12. Frezza C and Gottlieb E: Mitochondria in cancer: not just innocent bystanders. Semin Cancer Biol 19: 4-11, 2009.
13. King MP and Attardi G: Isolation of human cell lines lacking mitochondrial DNA. Methods Enzymol 264: 304-313, 1996.
14. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington S SJ and Capaldi RA: Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64: 985-993, 2004.